Tag Archives: Hurler syndrome

February, 2016

April, 2015

  • 8 April

    FDA Accepts ArmaGen’s IND for its Hurler Syndrome Candidate

    Privately-held biotech ArmaGen, Inc. announced today that US health regulators have accepted for review its investigational New Drug (IND) application for its drug for a rare lysosomal storage disease. The company, focused on developing novel therapies to treat severe neurological disorders, said that the US Food and Drug Administration (FDA) …